已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Intrahepatic cholangiocarcinoma treated with glass yttrium-90 radioembolization: A histopathologic study

医学 肝内胆管癌 坏死 放射科 单中心 回顾性队列研究 切除术 外科 总体生存率 肝切除术 核医学 化疗 生存分析 存活率 外科切除术
作者
Qian Yu,Peizi Li,Satvik Jain,Abdul Khan,Joseph Steiner,Chih‐Yi Liao,Joseph Wang Franses,Anjana A Pillai,John J. Fung,J. Michael Millis,Rakesh Navuluri,Steven M. Zangan,Brian S. Funaki,John Hart,Osman S. Ahmed,T Ha
出处
期刊:European Journal of Nuclear Medicine and Molecular Imaging [Springer Science+Business Media]
卷期号:53 (12): 6920-6929 被引量:1
标识
DOI:10.1007/s00259-026-07996-y
摘要

PURPOSE: To determine the degree of tumor necrosis on pathology and clinical outcomes among intrahepatic cholangiocarcinoma (iCCA) patients who were treated with transarterial radioembolization (TARE) and the bridge or downstaged to surgery. METHODS: A single center retrospective review was performed to include consecutive patients who underwent TARE using glass microspheres and then subsequently underwent surgical resection or transplant. Baseline characteristics, dosimetry, radiologic response, histological tumor necrosis, and overall survival were evaluated. A total of 20 patients (F: M = 14:6; age: 57.3 ± 10.8 years) underwent TARE and then received resection (n = 15) or living-donor liver transplant (n = 5). A total of 23 selective TARE (two segments or less) were delivered, with a mean dose 301.7 ± 177.5, whereas 18 lobar (left or right hepatic artery) doses were delivered, with a mean dose of 150.3 ± 44.1 Gy. Concurrent systemic therapy was administered in 15 patients. RESULTS: The mean time from the initial TARE to surgery was 7.1 ± 9.2 months. On pathology, complete tumor necrosis, > 90% necrosis, and extensive tumor necrosis (> 50%) were achieved in 1 (5.0%), 13 (65.0%), and 18 (90.0%) patients, respectively. The median survival time (MST) calculated from the time of surgery was 40.2 (95%CI: 15.3-not reached) months, with a 1-yr, 3-yr, and 5-yr OS of 88.2% (95CI: 60.6-96.9%), 57.8% (95%CI: 31.1-77.3%), and 19.8% (95%CI: 1.5-53.5%). From the time of initial TARE, the MST was 41.4 (95%CI:22.9-not reached) month, with a 1-yr, 3-yr, and 5-yr OS of 100%, 69.9% (95%CI: 42.0-86.3%), and 30.9% (95%CI: 9.1-56.3%). Whether the patient received concomitant systemic treatment was associated with extensive tumor necrosis on pathology (Odds Ratio: 16.0, 95%CI: 1.27-200.92, p = 0.032). CONCLUSION: Based on tumor explant data, TARE can result in substantial tumor necrosis in the treatment of iCCA, although complete necrosis is uncommon. The addition of systemic therapy appears to be associated with a higher likelihood of achieving extensive tumor necrosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
怜寒完成签到,获得积分10
刚刚
Zero完成签到,获得积分10
刚刚
1秒前
1秒前
赟糖发布了新的文献求助10
1秒前
2秒前
samifranco发布了新的文献求助10
3秒前
科研通AI6.3的应助被小鱼儿采纳,获得10
3秒前
4秒前
科研天才完成签到,获得积分10
4秒前
4秒前
4秒前
菠萝汽水发布了新的文献求助10
5秒前
土豆发布了新的文献求助10
5秒前
学僧完成签到,获得积分10
5秒前
5秒前
5秒前
529发布了新的文献求助10
6秒前
7秒前
沙一汀绯闻女友完成签到,获得积分10
7秒前
科研通AI6.3的应助被一期一会采纳,获得10
7秒前
7秒前
ATUMU发布了新的文献求助10
7秒前
靓丽翩跹完成签到,获得积分10
8秒前
马浩然发布了新的文献求助10
8秒前
Jasper的应助被Clarissa采纳,获得10
9秒前
我是666发布了新的文献求助10
9秒前
舒南晴发布了新的文献求助10
9秒前
小二郎的应助被优美的未来采纳,获得10
10秒前
szxa发布了新的文献求助10
10秒前
无极微光的应助被诺阳采纳,获得20
11秒前
十安完成签到,获得积分10
12秒前
12秒前
科研通AI6.2的应助被LYMS采纳,获得10
14秒前
华无剑的应助被LYMS采纳,获得10
14秒前
14秒前
15秒前
Jasper的应助被一条小杂鱼采纳,获得10
15秒前
17秒前
清爽秋荷发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179104
求助须知:如何正确求助?哪些是违规求助? 9569680
关于积分的说明 21806134
捐赠科研通 7774263
什么是DOI,文献DOI怎么找? 3433003
关于科研通互助平台的介绍 2556897
邀请新用户注册赠送积分活动 2478643